SC Filed 2019-04-18 Event — SEC 0000903423-19-000194 →

GLAXOSMITHKLINE PLC → Theravance Biopharma, Inc. TBPH

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

20 filings by this filer

19 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 7.84

5,262,895 shares short · +2.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $196K

Point72 Asset Mgmt

Other 13D/G Filings on Theravance Biopharma, Inc.

Filed	Form	Filer	Stake	Shares
2022-02-10	SC	GLAXOSMITHKLINE PLC	—	—	view →
2020-06-22	SC	GLAXOSMITHKLINE PLC	—	—	view →
2020-02-27	SC	GLAXOSMITHKLINE PLC	—	—	view →

Other Filings by GLAXOSMITHKLINE PLC

Filed	Form	Issuer	Stake	Shares
2022-02-10	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2021-09-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-09-16	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2021-05-25	SC	Innoviva, Inc. INVA	—	—	view →
2021-04-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-04-08	SC	Pandion Therapeutics, Inc.	—	—	view →
2021-02-12	SC	Innoviva, Inc. INVA	—	—	view →
2020-12-07	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-12-07	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2020-10-01	SC	Principia Biopharma Inc.	—	—	view →
2020-06-29	SC	Morphic Holding, Inc.	—	—	view →
2020-06-22	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2020-06-04	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-02-27	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2018-07-17	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2018-04-10	SC	Innoviva, Inc. INVA	—	—	view →
2018-02-13	SC	HTG MOLECULAR DIAGNOSTICS, INC	—	—	view →
2018-02-13	SC	CRISPR Therapeutics AG CRSP	—	—	view →
2018-02-13	SC	GENOCEA BIOSCIENCES, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →